当前位置: 首页 >> 检索结果
26. Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
作者: Jacqueline Maya.;Deepti Pant.;Yiran Fu.;Kaitlyn James.;Carolina Batlle.;Sarah Hsu.;Diana C Soria-Contreras.;Lydia L Shook.;Christopher Mow.;Marie-France Hivert.;Tanayott Thaweethai.;Camille E Powe.
来源: JAMA. 2025年334卷24期2186-2196页
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are contraindicated in pregnancy. Discontinuation of GLP-1RAs proximal to pregnancy could affect gestational weight gain and pregnancy outcomes.
27. Arsenic Exposure Reduction and Chronic Disease Mortality.
作者: Fen Wu.;Alexander van Geen.;Joseph Graziano.;Kazi Matin Ahmed.;Mengling Liu.;Maria Argos.;Faruque Parvez.;Imtiaz Choudhury.;Vesna N Slavkovich.;Tyler Ellis.;Tariqul Islam.;Alauddin Ahmed.;Muhammad G Kibriya.;Farzana Jasmine.;Mohammad Hasan Shahriar.;Rabiul Hasan.;Salma Akter Shima.;Golam Sarwar.;Ana Navas-Acien.;Habibul Ahsan.;Yu Chen.
来源: JAMA. 2025年334卷23期2104-2112页
Chronic exposure to arsenic in drinking water has been associated with increased chronic disease mortality. However, there is limited evidence on associations between reduced exposure and mortality risk.
29. Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.
作者: Michelle M Estrella.;Shoshana H Ballew.;Yingying Sang.;Morgan E Grams.;Josef Coresh.;Aditya Surapaneni.;Natalia Alencar de Pinho.;Johan Ärnlöv.;Hermann Brenner.;Juan-Jesus Carrero.;Teresa K Chen.;Debbie L Cohen.;Mary Cushman.;Ron T Gansevoort.;Shih-Jen Hwang.;Lesley A Inker.;Joachim H Ix.;Keiko Kabasawa.;Tsuneo Konta.;Jennifer S Lees.;Kevan R Polkinghorne.;Michael G Shlipak.;Robin W M Vernooij.;David C Wheeler.;Ashok Kumar Yadav.;Andrew S Levey.;Kai-Uwe Eckardt.; .
来源: JAMA. 2025年334卷21期1915-1926页
Estimated glomerular filtration rates (eGFRs) can differ according to whether creatinine or cystatin C is used for the eGFR calculation, but the prevalence and importance of these differences remain unclear.
31. An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial.
作者: Nestoras Mathioudakis.;Benjamin Lalani.;Mohammed S Abusamaan.;Mary Alderfer.;Defne Alver.;Adrian Dobs.;Brian Kane.;John McGready.;Kristin Riekert.;Benjamin Ringham.;Aliyah Shehadeh.;Fatmata Vandi.;Amal A Wanigatunga.;Daniel Zade.;Nisa M Maruthur.; .
来源: JAMA. 2025年334卷23期2079-2089页
Prediabetes is common, yet evidence-based lifestyle interventions are underutilized.
34. Lung Cancer in Nonsmoking Individuals: A Review.
Lung cancer in nonsmoking individuals (defined as people who have smoked fewer than 100 cigarettes in their lifetime) accounts for 15% to 20% of all lung cancer cases worldwide. In the US, the annual incidence of lung cancer in nonsmoking individuals is 14.4 to 20.8 per 100 000 person-years in females and 4.8 to 12.7 per 100 000 person-years in males.
37. Respiratory Syncytial Virus Vaccination in Adult Allogeneic Hematopoietic Cell Transplant Recipients.
作者: Jonas Lötscher.;Carla Simone Walti.;Stefanie Heller.;Fanny Hengy Linder.;Beatrice Drexler.;Sabine Gerull.;Michelle Hoffmann.;Roby Mathew.;Ramona Merki.;Miriam Ravelli.;Lucas Simeon.;Georg Stussi.;Isabelle Vock.;Jakob R Passweg.;Sarah Tschudin-Sutter.;Karoline Leuzinger.;Jörg P Halter.;Nina Khanna.
来源: JAMA. 2025年334卷16期1478-1480页 39. Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical Trial.
作者: Namasivayam Ambalavanan.;Waldemar A Carlo.;Kayla J Nowak.;Laura Elizabeth Wiener.;Shirley S Cosby.;Abhay J Bhatt.;Kristi L Watterberg.;Brenda B Poindexter.;Martin Keszler.;Carl T D'Angio.;Luc P Brion.;Vivek Narendran.;Carrie A Rau.;C Michael Cotten.;Matthew M Laughon.;Abhik Das.;Matthew A Rysavy.;Anna Maria Hibbs.;Janell Fuller.;Karen M Puopolo.;Anup Katheria.;Ravi M Patel.;Jennifer R Bermick.;Abbot R Laptook.;Irina Prelipcean.;Myra H Wyckoff.;Ryan Moore.;Stephanie L Merhar.;Robin K Ohls.;Bradley A Yoder.;Marta Perez.;Sarvin Ghavam.;Lauritz R Meyer.;Valerie Y Chock.;Sara B DeMauro.;Wesley M Jackson.;Deepali Handa.;Michele C Walsh.; .
来源: JAMA. 2025年334卷16期1452-1462页
Extremely preterm infants are at high risk for bronchopulmonary dysplasia (BPD) and death. Multiple small randomized clinical trials showed that a combination of budesonide with surfactant compared with surfactant alone reduced BPD or death.
|